136 related articles for article (PubMed ID: 38471063)
1. Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract.
DeFilipp Z; Damania AV; Kim HT; Chang CC; El-Jawahri A; McAfee SL; Bottoms AS; Toncheva V; Smith MM; Dolaher M; Perry L; White M; Diana B; Connolly S; Dey BR; Frigault MJ; Newcomb RA; O'Donnell PV; Spitzer TR; Mansour MK; Weber D; Ajami NJ; Hohmann E; Jenq RR; Chen YB
Blood Adv; 2024 May; 8(9):2074-2084. PubMed ID: 38471063
[TBL] [Abstract][Full Text] [Related]
2. Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity.
DeFilipp Z; Peled JU; Li S; Mahabamunuge J; Dagher Z; Slingerland AE; Del Rio C; Valles B; Kempner ME; Smith M; Brown J; Dey BR; El-Jawahri A; McAfee SL; Spitzer TR; Ballen KK; Sung AD; Dalton TE; Messina JA; Dettmer K; Liebisch G; Oefner P; Taur Y; Pamer EG; Holler E; Mansour MK; van den Brink MRM; Hohmann E; Jenq RR; Chen YB
Blood Adv; 2018 Apr; 2(7):745-753. PubMed ID: 29592876
[TBL] [Abstract][Full Text] [Related]
3. Treatment of intestinal graft-versus-host disease with unrelated donor fecal microbiota transplantation capsules: A case report.
Mao D; Jiang Q; Sun Y; Mao Y; Guo L; Zhang Y; Man M; Ouyang G; Sheng L
Medicine (Baltimore); 2020 Sep; 99(38):e22129. PubMed ID: 32957333
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial.
Zhao Y; Li X; Zhou Y; Gao J; Jiao Y; Zhu B; Wu D; Qi X
Front Immunol; 2021; 12():678476. PubMed ID: 34220825
[TBL] [Abstract][Full Text] [Related]
5. Fecal microbiota transfer for refractory intestinal graft-versus-host disease - Experience from two German tertiary centers.
Goeser F; Sifft B; Stein-Thoeringer C; Farowski F; Strassburg CP; Brossart P; Higgins PG; Scheid C; Wolf D; Holderried TAW; Vehreschild MJGT; Cruz Aguilar MR
Eur J Haematol; 2021 Aug; 107(2):229-245. PubMed ID: 33934412
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study of 19 cases of steroid-refractory gastrointestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with fecal microbiota transplantation].
Zheng YY; Yang XT; Lin GQ; Bian MR; Si YJ; Zhang XX; Zhang YM; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):401-407. PubMed ID: 37550190
[No Abstract] [Full Text] [Related]
7. Profiling the Fungal Microbiome after Fecal Microbiota Transplantation for Graft-versus-Host Disease: Insights from a Phase 1 Interventional Study.
van Lier YF; Rolling T; Armijo GK; Zhai B; Haverkate NJE; Meijer E; Nur E; Blom B; Peled JU; van den Brink MRM; Hohl TM; Hazenberg MD; Markey KA
Transplant Cell Ther; 2023 Jan; 29(1):63.e1-63.e5. PubMed ID: 36280104
[TBL] [Abstract][Full Text] [Related]
8. [Fecal microbiota transplantation for graft-versus-host disease in children and adults: methods, clinical effects, safety].
Goloshchapov OV; Chukhlovin AB; Bakin EA; Stanevich OV; Klementeva RV; Shcherbakov AA; Shvetsov AN; Suvorova MA; Bondarenko SN; Kucher MA; Kulagin AD; Zubarovskaya LS; Moiseev IS
Ter Arkh; 2020 Sep; 92(7):43-54. PubMed ID: 33346444
[TBL] [Abstract][Full Text] [Related]
9. Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients.
van Lier YF; Davids M; Haverkate NJE; de Groot PF; Donker ML; Meijer E; Heubel-Moenen FCJI; Nur E; Zeerleder SS; Nieuwdorp M; Blom B; Hazenberg MD
Sci Transl Med; 2020 Aug; 12(556):. PubMed ID: 32801142
[TBL] [Abstract][Full Text] [Related]
10. Multi-omics Analysis of a Fecal Microbiota Transplantation Trial Identifies Novel Aspects of Acute GVHD Pathogenesis.
Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Kazadi D; Halaweish H; Khan MH; Hoeschen A; Cao Q; Luo X; Kabage AJ; Lopez S; Ramamoorthy S; Holtan SG; Weisdorf DJ; Khoruts A; Staley C
Cancer Res Commun; 2024 Jun; 4(6):1454-1466. PubMed ID: 38767452
[TBL] [Abstract][Full Text] [Related]
11. [Fecal microbiota transplantation for acute graft-versus-host disease of the gut].
Kakihana K
Rinsho Ketsueki; 2017; 58(5):499-505. PubMed ID: 28592766
[TBL] [Abstract][Full Text] [Related]
12. Treating Steroid Refractory Intestinal Acute Graft-vs.-Host Disease With Fecal Microbiota Transplantation: A Pilot Study.
Qi X; Li X; Zhao Y; Wu X; Chen F; Ma X; Zhang F; Wu D
Front Immunol; 2018; 9():2195. PubMed ID: 30319644
[TBL] [Abstract][Full Text] [Related]
13. Fecal Microbiota Transplantation for Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation: Expanding the Horizon into Pediatrics.
Gray AN; DeFilipp Z
Transplant Cell Ther; 2023 Aug; 29(8):484-491. PubMed ID: 37169290
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic use and ileocolonic immune cells in patients receiving fecal microbiota transplantation for refractory intestinal GvHD: a prospective cohort study.
Spindelboeck W; Halwachs B; Bayer N; Huber-Krassnitzer B; Schulz E; Uhl B; Gaksch L; Hatzl S; Bachmayr V; Kleissl L; Kump P; Deutsch A; Stary G; Greinix H; Gorkiewicz G; Högenauer C; Neumeister P
Ther Adv Hematol; 2021; 12():20406207211058333. PubMed ID: 34987741
[TBL] [Abstract][Full Text] [Related]
15. Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
Jacob V; Crawford C; Cohen-Mekelburg S; Viladomiu M; Putzel GG; Schneider Y; Chabouni F; OʼNeil S; Bosworth B; Woo V; Ajami NJ; Petrosino JF; Gerardin Y; Kassam Z; Smith M; Iliev ID; Sonnenberg GF; Artis D; Scherl E; Longman RS
Inflamm Bowel Dis; 2017 Jun; 23(6):903-911. PubMed ID: 28445246
[TBL] [Abstract][Full Text] [Related]
16. Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot study.
Youngster I; Eshel A; Geva M; Danylesko I; Henig I; Zuckerman T; Fried S; Yerushalmi R; Shem-Tov N; Fein JA; Bomze D; Shimoni A; Koren O; Shouval R; Nagler A
Bone Marrow Transplant; 2024 Mar; 59(3):409-416. PubMed ID: 38212672
[TBL] [Abstract][Full Text] [Related]
17. Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut.
Kakihana K; Fujioka Y; Suda W; Najima Y; Kuwata G; Sasajima S; Mimura I; Morita H; Sugiyama D; Nishikawa H; Hattori M; Hino Y; Ikegawa S; Yamamoto K; Toya T; Doki N; Koizumi K; Honda K; Ohashi K
Blood; 2016 Oct; 128(16):2083-2088. PubMed ID: 27461930
[TBL] [Abstract][Full Text] [Related]
18. Intestinal Microbiome Changes in Fecal Microbiota Transplant (FMT)
Garza-González E; Mendoza-Olazarán S; Morfin-Otero R; Ramírez-Fontes A; Rodríguez-Zulueta P; Flores-Treviño S; Bocanegra-Ibarias P; Maldonado-Garza H; Camacho-Ortiz A
Can J Gastroenterol Hepatol; 2019; 2019():4549298. PubMed ID: 31976311
[TBL] [Abstract][Full Text] [Related]
19. Acute Steroid-Refractory Gastrointestinal Graft-Versus-Host Disease Is Not Associated With Significant Differences in Gut Taxonomic Composition Compared to Steroid-Sensitive Gastrointestinal Graft-Versus-Host Disease Immediately Before Onset of Disease.
Zeng K; Brewster R; Kang JB; Tkachenko E; Brooks E; Bhatt AS; Fodor AA; Andermann TM
Transplant Cell Ther; 2024 Feb; 30(2):237.e1-237.e9. PubMed ID: 37944820
[TBL] [Abstract][Full Text] [Related]
20. Fecal transplantation for treatment of inflammatory bowel disease.
Imdad A; Nicholson MR; Tanner-Smith EE; Zackular JP; Gomez-Duarte OG; Beaulieu DB; Acra S
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012774. PubMed ID: 30480772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]